CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
77 hedge funds and large institutions have $145M invested in Concert Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 30 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
54% less call options, than puts
Call options by funds: $174K | Put options by funds: $380K
Holders
77
Holding in Top 10
–
Calls
$174K
Puts
$380K
Top Buyers
| 1 | +$3.07M | |
| 2 | +$2.94M | |
| 3 | +$1.2M | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$566K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$342K |
Top Sellers
| 1 | -$2.17M | |
| 2 | -$1.06M | |
| 3 | -$1.05M | |
| 4 |
ISL
Ingalls & Snyder LLC
New York
|
-$610K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$576K |